Los puntos clave no están disponibles para este artículo en este momento.
CEE-based hormone therapy delivered near the time of menopause provides neither cognitive benefit nor detriment. If administered in older women, it results in small decrements in several cognitive domains that remain for many years.
Espeland et al. (Tue,) studied this question.